Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Infectious disease diagnostics industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends (USD Milion)
2.1.2 Product trends
2.1.3 Technology trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional trends (USD Milion)
Chapter 3 Infectious Disease Diagnostics Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing incidence of infectious diseases
3.2.1.2 Rise in demand for point-of-care diagnostic testing
3.2.1.3 Technological advancement in infectious disease diagnostics
3.2.1.4 Rise in awareness regarding early diagnosis detection
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled professionals
3.2.2.2 Lack of awareness regarding infection control and prevention
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By application
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Abbott Laboratories
4.1.2 Becton Dickinson and Company
4.1.3 BioMerieus SA
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Infectious Disease Diagnostics Market, By Product
5.1 Key segment trends
5.2 Instruments
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Reagents, kits & consumables
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Services
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Infectious Disease Diagnostics Market, By Technology
6.1 Key segment trends
6.2 Clinical microbiology
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Polymerase chain reaction (PCR)
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 In situ hybridization
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Isothermal nucleic acid amplification technology (INAAT)
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Immunodiagnostics
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Other technology
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Infectious Disease Diagnostics Market, By Application
7.1 Key segment trends
7.2 COVID-19
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Gastrointestinal tract infections
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Respiratory diseases
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Sexually transmitted infections
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Tuberculosis
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.7 Hospital acquied infection
7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.8 Mosquito-borne diseases
7.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.9 Other infectious diseases
7.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Infectious Disease Diagnostics Market, By End-use
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Clinics
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Diagnostics laboratories
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Research institutes
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.6 Others
8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Infectious Disease Diagnostics Market Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Poland
9.3.7 Switzerland
9.3.8 Sweden
9.3.9 Denmark
9.3.10 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Thailand
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.5.6 Peru
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Turkey
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton Dickinson and Company
10.3 BioMerieus SA
10.4 Bio-Rad Laboratories
10.5 Danaher Corporation
10.6 F Hoffman-La Roche
10.7 Hologic Inc.
10.8 Siemens Healthineers
10.9 Qiagen Inc.
10.10 Thermo Fisher Scientific Inc.
